Arkolith/Insider Trading/HARP/Form 4

Hunt Ronald

Director, 10% OwnerHarpoon Therapeutics, Inc. (HARP) · full profile →Form 4 · filed Mar 27, 2023
Net Buying
Open-Market Buys
$10.0M
Open-Market Sells
$0
Net Open-Market Flow
$10.0M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 23, 2023Buy(P)10K$1000.00$10.0M10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 23, 2023Buy(P)3.0M——3.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-009741) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML